Original Research
Published on 12 Apr 2021
Ellagic Acid Attenuates BLM-Induced Pulmonary Fibrosis via Inhibiting Wnt Signaling Pathway
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.639574
- 4,388 views
- 19 citations
Type at least 3 characters
571 articles
Articles
Original Research
Published on 12 Apr 2021
Potential Mechanism Prediction of Herbal Medicine for Pulmonary Fibrosis Associated with SARS-CoV-2 Infection Based on Network Analysis and Molecular Docking
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.602218
- 5,953 views
- 12 citations
Editorial
Published on 12 Apr 2021
Editorial: Phosphodiesterases as Drug Targets in Airway and Inflammatory Diseases
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.657596
- 1,772 views
- 2 citations
Original Research
Published on 05 Apr 2021
Possible Tracheal Relaxant and Antimicrobial Effects of the Essential Oil of Ethiopian Thyme Species (Thymus serrulatus Hochst. ex Benth.): A Multiple Mechanistic Approach
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.615228
- 4,498 views
- 5 citations
Original Research
Published on 30 Mar 2021
Brusatol Derivative–34 Attenuates Allergic Airway Inflammation Via Inhibition of the Spleen Tyrosine Kinase Pathway
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.587417
- 2,272 views
- 5 citations
Original Research
Published on 25 Mar 2021
Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.646676
- 13,891 views
- 48 citations
Original Research
Published on 23 Mar 2021
COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.633680
- 186,647 views
- 83 citations
Mini Review
Published on 16 Mar 2021
Treatment of Cystic Fibrosis: From Gene- to Cell-Based Therapies
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.639475
- 25,492 views
- 25 citations
Original Research
Published on 08 Mar 2021
Oral Formulation of Angiotensin-(1-7) Promotes Therapeutic Actions in a Model of Eosinophilic and Neutrophilic Asthma
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.557962
- 3,242 views
- 4 citations
Original Research
Published on 22 Feb 2021
The Influenza A Virus H3N2 Triggers the Hypersusceptibility of Airway Inflammatory Response via Activating the lncRNA TUG1/miR-145-5p/NF-ÎşB Pathway in COPD
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.604590
- 3,733 views
- 10 citations
Original Research
Published on 22 Feb 2021
Drug Repurposing and Polypharmacology to Fight SARS-CoV-2 Through Inhibition of the Main Protease
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.636989
- 4,885 views
- 30 citations
Original Research
Published on 12 Feb 2021
Effectiveness of Benralizumab in Improving the Quality of Life of Severe Eosinophilic Asthmatic Patients: Our Real-Life Experience
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.631660
- 5,121 views
- 17 citations
Original Research
Published on 10 Feb 2021
S1PR2 Inhibition Attenuates Allergic Asthma Possibly by Regulating Autophagy
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2020.598007
- 4,996 views
- 22 citations
Original Research
Published on 05 Feb 2021
Effectiveness and Nephrotoxicity of Intravenous Polymyxin B in Chinese Patients With MDR and XDR Nosocomial Pneumonia
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2020.579069
- 3,454 views
- 12 citations
Case Report
Published on 29 Jan 2021
Case Report: Fatal Multiorgan Failure and Heterochronous Pneumonitis Following Pembrolizumab Treatment in a Patient With Large-Cell Neuroendocrine Carcinoma of Lung
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2020.569466
- 3,852 views
- 11 citations
Original Research
Published on 27 Jan 2021
Protective Effect of Arbidol Against Pulmonary Fibrosis and Sepsis in Mice
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2020.607075
- 3,841 views
- 7 citations